Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arrhythmia Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02478294
What this trial is testing

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke

Who this might be right for
Atrial FibrillationStrokeSystemic Embolism
The First Affiliated Hospital with Nanjing Medical University 474
Not applicableStudy completedNCT02273700
What this trial is testing

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention

Who this might be right for
Atrial Fibrillation
Centre Hospitalier Universitaire de Nīmes 5
Large-scale testing (Phase 3)Study completedNCT02801669
What this trial is testing

Study of DU-176b Aged 80 Years or Older

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Co., Ltd. 984
Not applicableEnrolling By InvitationNCT05341986
What this trial is testing

Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation With an Electronic Clinical Decision Support Tool

Who this might be right for
Atrial Fibrillation
Oregon Health and Science University 36
Large-scale testing (Phase 3)Looking for participantsNCT07430956
What this trial is testing

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

Who this might be right for
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals 2,628
Large-scale testing (Phase 3)Study completedNCT06675500
What this trial is testing

Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery

Who this might be right for
Atrial Fibrillation (AF)Magnesium SulfatePost Cardiac Surgery Patients
Ain Shams University 130
Not applicableLooking for participantsNCT06949319
What this trial is testing

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New Onset+4 more
Nedim Tojaga 150
Not applicableLooking for participantsNCT06823466
What this trial is testing

Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants

Who this might be right for
Ischemic StrokeOral AnticoagulationAtrial Fibrillation (AF)+2 more
University of L'Aquila 200
Testing effectiveness (Phase 2)Study completedNCT00232297
What this trial is testing

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS

Who this might be right for
ArrhythmiaTachycardia, VentricularVentricular Fibrillation
Sanofi 153
Large-scale testing (Phase 3)Ended earlyNCT05643573
What this trial is testing

Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Who this might be right for
Prevention of Stroke or Systemic EmbolismAtrial Fibrillation
Bayer 14,830
Testing effectiveness (Phase 2)Study completedNCT01227629
What this trial is testing

PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 502
Testing effectiveness (Phase 2)Study completedNCT00410020
What this trial is testing

Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet

Who this might be right for
Atrial FibrillationDiet Therapy
Assistance Publique - Hôpitaux de Paris 130
Not applicableActive Not RecruitingNCT06580275
What this trial is testing

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

Who this might be right for
Atrial FibrillationStroke Prevention
Conformal Medical, Inc 80
Not applicableNot Yet RecruitingNCT06355986
What this trial is testing

Computerized Decision Support to Prevent Stroke in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
Brigham and Women's Hospital 2,500
Post-approval studies (Phase 4)UnknownNCT02646267
What this trial is testing

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
The First Affiliated Hospital with Nanjing Medical University 210
Post-approval studies (Phase 4)UnknownNCT00247533
What this trial is testing

Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia

Who this might be right for
StrokeCoronary Artery DiseaseArrhythmia
Far Eastern Memorial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00709384
What this trial is testing

Prevention of Atrial Tachycardia After a Right Atriotomy II

Who this might be right for
Atrial Flutter
Aarhus University Hospital Skejby 14
Not applicableUnknownNCT03784586
What this trial is testing

Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients

Who this might be right for
Myotonic Dystrophy 1Sudden Cardiac Death
University of Campania Luigi Vanvitelli 70
Large-scale testing (Phase 3)UnknownNCT05084118
What this trial is testing

Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Who this might be right for
Atrial FibrillationPostoperative Complications
Medical University of Vienna 164
Not applicableEnded earlyNCT03259893
What this trial is testing

Secondary Prevention of Atrial Fibrilation

Who this might be right for
Atrial FibrillationRisk FactorsRisk Reduction Behavior
Boston Medical Center 3
Next Page